SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : NASI (North American Scientific, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: cmpg who wrote (460)3/1/1998 5:50:00 PM
From: dfloydr  Respond to of 658
 
Another big Plus for THRX, warranting a somewhat higher multiple than might otherwise seem reasonable, is their alliance with Johnson & Johnson. With J&J doing the selling, THRX can focus on cranking out the seeds.

Floyd

PS: even so a P/E of 90 is getting up there....



To: cmpg who wrote (460)3/2/1998 1:04:00 AM
From: Know Genius  Respond to of 658
 
If you guys don't mind me chiming in. I believe the 10m seed a week projection is real and conservative. Management says they will produce at that level and I am sure they will. Furthermore I believe the difference between Pd-103 and I-125 will soon be moot.



To: cmpg who wrote (460)3/8/1998 8:59:00 AM
From: Westerner  Respond to of 658
 
>>IBT. I believe they intend to enter the field with Pd-103, not I-125. I could be wrong, here.<<

This is correct. IBt use a cyclotron method for isotope production so they will produce Pd103 and not I125. So far their product is not FDA approved in the USA.